Aulin Sherry's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Sep 7, 2022
- Accession no.
- 0001209191-22-049015
- Filed
- Sep 7, 2022
- Trade date
- Sep 2, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 5 derivative transactions. Open-market sales total $607.6K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aulin SherryCIK 0001862144 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | Common Shares | MOption exerciseAcquired | +9,000 | $9.44 | +$84,960 | 9,000 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseAcquired | +32 | $7.49 | +$239.68 | 9,032 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseAcquired | +813 | $8.40 | +$6,829.2 | 9,845 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseAcquired | +2,292 | $3.10 | +$7,105.2 | 12,137 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseAcquired | +6,511 | $4.75 | +$30,927.25 | 18,648 | Direct | |
| Sep 2, 2022 | Common Shares | FTax withholdingDisposed | −3,293 | $39.53 | −$130,172.29 | 15,355 | Direct | |
| Sep 2, 2022 | Common Shares | SSaleDisposed | −15,355 | $39.57 | −$607,597.35 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | Common Shares | MOption exerciseDisposed | −9,000 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseDisposed | −32 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseDisposed | −813 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseDisposed | −2,292 | $0.00 | $0 | 0 | Direct | |
| Sep 2, 2022 | Common Shares | MOption exerciseDisposed | −6,511 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.